Go to content
Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 30 jun 2016 - 07:00
Statutaire naam Vivoryon Therapeutics N.V.
Titel Probiodrug and Crossbeta Biosciences enter into a strategic partnership in the field of Alzheimer's disease biomarkers
Bericht Probiodrug and Crossbeta Biosciences enter into a strategic partnership in the field of Alzheimer's disease biomarkers License and supply agreement is based on Crossbeta's proprietary technology and supports Probiodrug's biomarker development activities

Datum laatste update: 07 februari 2025